Practical Aspects of Switching to a Physiologic, Basal Insulin Formulation - Vivian Fonseca, MD, FRCP, Program Chair

Practical Aspects of Switching to a Physiologic, Basal Insulin Formulation - Vivian Fonseca, MD, FRCP, Program Chair

Targeting Diabetic Patients Who Should be Initiated on or Switched to a Long-Acting, Physiologic Insulin - How to Switch? Patient Information-Sharing, Dosing Considerations, and Improving Regimen Adherence and Safety Through Improved Insulin-Delivery Devices and Patient Education.

Published

Created by

CMEducation Resources symposium

Related Presenters

Vivian Fonseca, FRCP, MD

Vivian Fonseca, FRCP, MD

Professor of Medicine and Pharmacology
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
Past President, Science and Medicine American Diabetes Association (ADA)